[Efficacy of moxonidine, an imidazoline receptor agonist, in patients with essential hypertension]

Related Experiment Video

Updated: Oct 30, 2026

Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
04:59

Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia

Published on: May 30, 2025

E V Baliakina, I F Patrusheva, E E Rynskova

    Terapevticheskii Arkhiv
    |April 9, 1998
    PubMed
    Abstract

    Insights

    Zint (moxonidine) effectively lowers blood pressure in patients with essential hypertension. This central-acting hypotensive drug also demonstrated a reduction in platelet aggregation.

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine
    • Hypertension Management

    Background:

    • Essential hypertension is a prevalent cardiovascular condition requiring effective treatment.
    • Central antihypertensive agents offer a distinct mechanism for blood pressure control.
    • Understanding the impact of moxonidine on hemodynamic and platelet function is crucial.

    Purpose of the Study:

    • To evaluate the efficacy of zint (moxonidine) in managing essential hypertension.
    • To assess the effects of zint on hemodynamic parameters and platelet activity.
    • To determine if zint therapy represents a physiological approach to hypertension control.

    Main Methods:

    • A study involving 30 patients diagnosed with essential hypertension.
    • Treatment with zint (moxonidine) at a daily dose of 0.4 mg for three months.
    • Assessment of hemodynamics, including blood pressure and heart rate, and platelet functional activity.

    Main Results:

    • Significant reductions in systolic (23 mmHg), diastolic (15 mmHg), and mean arterial pressure (17 mmHg) were observed.
    • A decrease in heart rate by 5 beats/min was noted.
    • A notable reduction in adenosine diphosphate (ADP)-induced platelet aggregation was evident, with negligible changes in myocardial hypertrophy.

    Conclusions:

    • Zint (moxonidine) therapy demonstrates significant efficacy in lowering blood pressure in patients with essential hypertension.
    • The observed decrease in platelet aggregation suggests potential additional cardiovascular benefits.
    • Moxonidine therapy may offer a physiological approach to managing arterial hypertension.

    Related Concept Videos

    Antihypertensive Drugs: Vasodilators01:23

    Antihypertensive Drugs: Vasodilators

    Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
    Cholinergic Antagonists: Pharmacological Actions01:28

    Cholinergic Antagonists: Pharmacological Actions

    Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
    Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
    Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

    Direct-Acting Cholinergic Agonists: Pharmacological Actions

    Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
    Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

    Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

    α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
    α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
    Cholinergic Antagonists: Therapeutic Uses01:26

    Cholinergic Antagonists: Therapeutic Uses

    Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
    Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
    Cholinergic Antagonists: Pharmacokinetics01:24

    Cholinergic Antagonists: Pharmacokinetics

    Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and the conjunctiva.